Trial Profile
An Observational Study to Assess Correlation Between Prostate Specific Antigen and Beck Anxiety Index in Prostate Cancer Patients Under Hormonal Therapy [bicalutamide, goserelin].
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CHAMPION
- Sponsors AstraZeneca
- 27 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Sep 2008 Actual start date changed from Jun 2007 to May 2007 as reported by Clinicaltrials.gov.
- 08 Sep 2008 Planned end date added (1 Apr 2009) as reported by ClinicalTrials.gov.